IPO, OpenAI
Digest more
Groww IPO GMP has risen ahead of its issue launch next week in the primary market. The grey market premium (GMP) for the ...
Netskope expects a major lift from its recently completed IPO, which has put the company on the same playing field alongside ...
The medical supplies maker could raise about $5 billion in a deal that could value the company at as much as $50 billion.
The decent GMP despite elevated valuations indicates that the market is looking at it more as a technology company which can ...
Inflammation biotech Evommune plans to take the leap into public waters with an expected initial public offering price of $15 ...
The trajectory of the Lenskart IPO GMP shows how exuberance has given way to caution, with the market asking for a bit more ...
Medline disclosed on Tuesday that its revenue rose 9.7% in the first half of 2025, as one of the world's largest makers of ...
11hon MSN
Lenskart IPO vs Studds Accessories IPO vs Orkla India IPO: What GMP signals about listing premium?
Lenskart, Orkla India, and Studds Accessories are the 3 mainboard IPOs open for subscription. Orkla attracts ...
With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to ...
OpenAI is considering filing with securities regulators as soon as the second half of 2026, people familiar with the matter ...
The work you do a full year or two before your IPO shapes your valuation, your reputation and, above all, your future as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback